Search

everythinglearnresearchcommunity

for

Search:↓

Pregnancy right after giving birth in mice lacking IL-10 causes milk that leads to liver issues and hair loss in their babies.

Salivary vitamin D and IL-6 could help diagnose and manage non-scarring alopecia.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Wound healing can help prevent hair loss from chemotherapy in young rats by increasing interleukin-1β signaling.

Higher IL-37 levels are linked to more severe alopecia areata, but the gene variation doesn't affect disease risk.

A mutation in the IL2RA gene increases the risk of alopecia areata.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

Platelet Rich Plasma reduces psoriasis symptoms but isn't enough alone for treatment.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

Interleukin-15 can help hair growth and protect hair follicles.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

IL10_ApoEVs improve skin healing and reduce scarring.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

PRP-exosomes improve hair growth and reduce inflammation.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

A 3-month treatment improved PCOS symptoms and reduced certain immune proteins.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

Higher IL-17A levels indicate more severe alopecia areata.

Ajwain seed extract improved skin healing and hair growth in a mouse skin irritation model.

Patients with Alopecia Areata have higher levels of certain inflammatory markers.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Targeting IL-15 may help treat Alopecia Areata.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.